Iovance Biotherapeutics' most important product has strong momentum right now. However, the company faces significant challenges that make the stock risky. Iovance could soar if it can overcome the ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Kaitlyn Wells and Katie Okamoto The dirty little secret of so-called ...